EGFR-Mutated NSCLC: Clinical Practice Assessment and Gap Analysis

被引：0
|
作者：
Herrmann, Tara [1 ]
Hamarstrom, Elaine [2 ]
Ramalingam, Suresh [3 ]
机构：
[1] Medscape Educ, Ft Sam Houston, TX USA
[2] Medscape Educ, New York, NY USA
[3] Emory Univ, Winship Canc Inst, Med Oncol, Atlanta, GA 30322 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
EGFR; T790M; Education; molecular testing;
D O I：
10.1016/j.jtho.2016.11.1716
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.02b-049
引用
收藏
页码：S1218 / S1219
页数：2
相关论文
共 50 条
  • [1] Clinical analysis of the presence of comutations in patients with EGFR-mutated NSCLC
    Rubio, Jaime
    Santolaya, Carlota
    Fernandez, Marina
    Villalba, Paula Lucia
    Avedillo, Mercedes
    Garcia-Foncillas, Jesus
    Domine, Manuel
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] Osimertinib in Resected EGFR-Mutated NSCLC
    Tsuboi, Masahiro
    Herbst, Roy S.
    Wu, Yi-Long
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (14): : 1341 - 1342
  • [3] Osimertinib with Chemotherapy in EGFR-Mutated NSCLC
    van Doorn-Khosrovani, Sahar Barjesteh van Waalwijk
    Badrising, Sushil K.
    Burgers, Sjaak
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (05): : 478 - 479
  • [4] Osimertinib in EGFR-Mutated Advanced NSCLC
    Yan, Kelvin
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (19): : 1863 - 1863
  • [5] Gefitinib Approved for EGFR-Mutated NSCLC
    不详
    CANCER DISCOVERY, 2015, 5 (09) : 896 - 896
  • [6] EGFR-mutated NSCLC: A roadmap to treatment sequences
    Girard, Nicolas
    MED, 2024, 5 (09): : 1044 - 1047
  • [7] Resistance landscape to almonertinib in EGFR-mutated NSCLC
    Tian, M.
    Lu, Z.
    Chen, S.
    Lu, G.
    Bu, F.
    Deng, W.
    Ding, R.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1017 - S1017
  • [8] Clinical outcomes in Black patients with EGFR-mutated NSCLC treated with osimertinib
    Belani, Neel
    Rizwan, Farsha
    Hasler, Jill
    Bauman, Jessica
    Mitchell, Khadijah
    Borghaei, Hossein
    Bodor, Joseph N.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2024, 33 (09)
  • [9] EGFR-mutated NSCLC: practice-changing results and other notable findings
    不详
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2023, 16 : S188 - S192
  • [10] Clinical advances in EGFR-TKI combination therapy for EGFR-mutated NSCLC: a narrative review
    Zhang, Qianru
    Wang, Ruo
    Xu, Lu
    TRANSLATIONAL CANCER RESEARCH, 2023, 12 (12) : 3764 - 3778
12345